|
|
||||||||
From the Departments of Neurology (Drs. Hoogervorst, van Winsen, Eikelenboom, Kalkers, Uitdehaag, and Polman) and Clinical Epidemiology and Biostatistics (Dr. Uitdehaag), Academic Hospital, Free University, Amsterdam, the Netherlands.
Address correspondence and reprint requests to Dr. Hoogervorst, Academic Hospital "Vrije Universiteit," Department of Neurology, Postbox 7057, 1007 MB Amsterdam, the Netherlands; e-mail: e.hoogervorst{at}azvu.nl
OBJECTIVE: To compare the recently developed Guys Neurologic Disability Scale (GNDS), based on patient self-report, with both neurologist rating of neurologic examination abnormalities using the Expanded Disability Status Scale (EDSS) and observations of functional impairment on the Multiple Sclerosis Functional Composite (MSFC) in the assessment of disease impact in MS.
METHODS: Two hundred ninety MS patients were recruited at an outpatient clinic. Impairment and disability were assessed using GNDS, EDSS, and MSFC. Correlations between GNDS, EDSS, MSFC, and their corresponding components were studied for the total population, MS phenotypes, and three disability strata.
RESULTS: Mean scores were 4.6 (SD, 2.0) for EDSS, 0.0 (SD, 0.8) for MSFC, and 14.6 (SD, 7.9) for GNDS. Good correlations were found between GNDS and EDSS (r = 0.73), between GNDS and MSFC (r = -0.68), and between different subcategories of the GNDS and EDSS, MSFC, and their corresponding components. Remarkably good correlations were found between lower limb function and all three scales. Poor correlations were also found, especially between different measurements focusing on cognitive function.
CONCLUSION: The good correlations between GNDS and both EDSS and MSFC were mainly due to the importance of spinal-cordrelated neurologic functions in all three scoring systems. A marked discrepancy was found for the assessment of cognition between objective measurements and subjective complaints. Because patients self-reporting correlates well with results of physical examination, GNDS can offer a valuable way to measure disease impact in MS. However, GNDS is not an adequate screen of cognitive dysfunction.
This article has been cited by other articles:
![]() |
J. Kragt, B. van Amerongen, J Killestein, C. Dijkstra, B. Uitdehaag, C. Polman, and P Lips Higher levels of 25-hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in women Multiple Sclerosis, January 1, 2009; 15(1): 9 - 15. [Abstract] [PDF] |
||||
![]() |
R.J. Fox, J.-C. Lee, and R.A. Rudick Optimal reference population for the multiple sclerosis functional composite Multiple Sclerosis, August 1, 2007; 13(7): 909 - 914. [Abstract] [PDF] |
||||
![]() |
A Creange, I Serre, M Levasseur, D Audry, A Nineb, D Boerio, T Moreau, P Maison, and Reseau SINDEFI-SEP Walking capacities in multiple sclerosis measured by global positioning system odometer Multiple Sclerosis, March 1, 2007; 13(2): 220 - 223. [Abstract] [PDF] |
||||
![]() |
T E Sherman, L J Rapport, R A Hanks, K A Ryan, P A Keenan, O Khan, and R P Lisak Predictors of well-being among significant others of persons with multiple sclerosis Multiple Sclerosis, March 1, 2007; 13(2): 238 - 249. [Abstract] [PDF] |
||||
![]() |
L Julian, N M Merluzzi, and D C Mohr The relationship among depression, subjective cognitive impairment, and neuropsychological performance in multiple sclerosis Multiple Sclerosis, January 1, 2007; 13(1): 81 - 86. [Abstract] [PDF] |
||||
![]() |
J J Kragt, J M Nielsen, F A. van der Linden, B M. Uitdehaag, and C H Polman How similar are commonly combined criteria for EDSS progression in multiple sclerosis? Multiple Sclerosis, November 1, 2006; 12(6): 782 - 786. [Abstract] [PDF] |
||||
![]() |
V. de Groot, H. Beckerman, B. M. J. Uitdehaag, H. C. W. de Vet, G. J. Lankhorst, C. H. Polman, and L. M. Bouter The usefulness of evaluative outcome measures in patients with multiple sclerosis Brain, October 1, 2006; 129(10): 2648 - 2659. [Abstract] [Full Text] [PDF] |
||||
![]() |
J J Kragt, F A. van der Linden, J M Nielsen, B M. Uitdehaag, and C H Polman Clinical impact of 20% worsening on Timed 25-foot Walk and 9-hole Peg Test in multiple sclerosis Multiple Sclerosis, September 1, 2006; 12(5): 594 - 598. [Abstract] [PDF] |
||||
![]() |
H Hildebrandt, H K Hahn, J A Kraus, A Schulte-Herbruggen, B Schwarze, and G Schwendemann Memory performance in multiple sclerosis patients correlates with central brain atrophy Multiple Sclerosis, August 1, 2006; 12(4): 428 - 436. [Abstract] [PDF] |
||||
![]() |
M S. Deloire, M C Bonnet, E Salort, Y Arimone, M Boudineau, K G Petry, and B Brochet How to detect cognitive dysfunction at early stages of multiple sclerosis? Multiple Sclerosis, August 1, 2006; 12(4): 445 - 452. [Abstract] [PDF] |
||||
![]() |
Y. Goverover, N. Chiaravalloti, and J. DeLuca The relationship between self-awareness of neurobehavioral symptoms, cognitive functioning, and emotional symptoms in multiple sclerosis Multiple Sclerosis, April 1, 2005; 11(2): 203 - 212. [Abstract] [PDF] |
||||
![]() |
R. A. Marrie, G. J Chelune, D. M Miller, and J. A Cohen Subjective cognitive complaints relate to mild impairment of cognition in multiple sclerosis Multiple Sclerosis, February 1, 2005; 11(1): 69 - 75. [Abstract] [PDF] |
||||
![]() |
E L. Hoogervorst, J N. Zwemmer, B Jelles, C H Polman, and B M. Uitdehaag Multiple Sclerosis Impact Scale (MSIS-29): relation to established measures of impairment and disability Multiple Sclerosis, October 1, 2004; 10(5): 569 - 574. [Abstract] [PDF] |
||||
![]() |
O.R. Pearson, M.E. Busse, R.W.M. van Deursen, and C.M. Wiles Quantification of walking mobility in neurological disorders QJM, August 1, 2004; 97(8): 463 - 475. [Full Text] [PDF] |
||||
![]() |
E L. Hoogervorst, N F Kalkers, G R Cutter, B M. Uitdehaag, and C H Polman The patient's perception of a (reliable) change in the Multiple Sclerosis Functional C omposite Multiple Sclerosis, February 1, 2004; 10(1): 55 - 60. [Abstract] [PDF] |
||||
![]() |
S. R Schwid, C. M Tyler, E. A Scheid, A. Weinstein, A. D Goodman, and M. P McDermott Cognitive fatigue during a test requiring sustained attention: a pilot study Multiple Sclerosis, October 1, 2003; 9(5): 503 - 508. [Abstract] [PDF] |
||||
![]() |
S. M Gold, H. Schulz, A. Monch, K.-H. Schulz, and C. Heesen Cognitive impairment in multiple sclerosis does not affect reliability and validity of self-report health measures Multiple Sclerosis, August 1, 2003; 9(4): 404 - 410. [Abstract] [PDF] |
||||
![]() |
E L J Hoogervorst, M J Eikelenboom, B M J Uitdehaag, and C H Polman One year changes in disability in multiple sclerosis: neurological examination compared with patient self report J. Neurol. Neurosurg. Psychiatry, April 1, 2003; 74(4): 439 - 442. [Full Text] [PDF] |
||||
![]() |
J. A. Cohen, G. R. Cutter, J. S. Fischer, A. D. Goodman, F. R. Heidenreich, M. F. Kooijmans, A. W. Sandrock, R. A. Rudick, J. H. Simon, N. A. Simonian, et al. Benefit of interferon {beta}-1a on MSFC progression in secondary progressive MS Neurology, September 10, 2002; 59(5): 679 - 687. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. J. Hoogervorst, N. F. Kalkers, B. M. J. Uitdehaag, and C. H. Polman A Study Validating Changes in the Multiple Sclerosis Functional Composite Arch Neurol, January 1, 2002; 59(1): 113 - 116. [Abstract] [Full Text] [PDF] |
||||
![]() |
E L. Hoogervorst, N F Kalkers, L M. van Winsen, B M. Uitdehaag, and C H Polman Differential treatment effect on measures of neurologic exam, functional impairment and patient self-report in multiple sclerosis Multiple Sclerosis, October 1, 2001; 7(5): 335 - 339. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |